| # | Drug | Count |
|---|---|---|
| 0 | ECULIZUMAB | 81 |
| 1 | OXALIPLATIN | 50 |
| 2 | FLUOROURACIL | 41 |
| 3 | FLUOROURACIL CREAM, 0.5% | 41 |
| 4 | OMEPRAZOLE | 27 |
| 5 | OMEPRAZOLE MAGNESIUM | 27 |
| 6 | PREDNISONE | 25 |
| 7 | CYCLOSPORINE | 21 |
| 8 | FUROSEMIDE | 18 |
| 9 | BEVACIZUMAB | 17 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TAFENOQUINE | 1 | 0.0152 |
| 1 | TOLMETIN SODIUM | 2 | 0.0118 |
| 2 | DANICOPAN | 3 | 0.0097 |
| 3 | CROVALIMAB | 1 | 0.0083 |
| 4 | MEFLOQUINE HYDROCHLORIDE | 1 | 0.0064 |
| 5 | ARTEMETHER AND LUMEFANTRINE | 1 | 0.0051 |
| 6 | IPTACOPAN | 4 | 0.0050 |
| 7 | PEGCETACOPLAN | 5 | 0.0026 |
| 8 | PHENOBARBITAL, HYOSCYAMINE SULFATE, ATROPINE SULFATE, SCOPOLAMINE HYDROBROMIDE | 2 | 0.0022 |
| 9 | PALONOSETRON HYDROCHLORIDE | 10 | 0.0019 |
| # | Drug class | Count |
|---|---|---|
| 0 | Complement Inhibitor [EPC] | 84 |
| 1 | Platinum-based Drug [EPC] | 69 |
| 2 | Corticosteroid [EPC] | 64 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 52 |
| 4 | Proton Pump Inhibitor [EPC] | 38 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 33 |
| 6 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 26 |
| 7 | Calcineurin Inhibitor Immunosuppressant [EPC] | 21 |
| 8 | Loop Diuretic [EPC] | 20 |
| 9 | Benzodiazepine [EPC] | 18 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Complement Factor D Inhibitor [EPC] | 3 | 0.0097 |
| 1 | Complement C5 Inhibitor [EPC] | 1 | 0.0083 |
| 2 | CD33-directed Immunoconjugate [EPC] | 6 | 0.0016 |
| 3 | Complement Inhibitor [EPC] | 84 | 0.0015 |
| 4 | Parenteral Iron Replacement [EPC] | 13 | 0.0009 |
| 5 | Uric Acid-specific Enzyme [EPC] | 3 | 0.0008 |
| 6 | Nucleoside Analog Antifungal [EPC] | 1 | 0.0007 |
| 7 | CD38-directed Cytolytic Antibody [EPC] | 4 | 0.0007 |
| 8 | Neuraminidase Inhibitor [EPC] | 1 | 0.0004 |
| 9 | Monobactam Antibacterial [EPC] | 1 | 0.0004 |